Treatment Strategy: Calming the Inflammatory Fire

Because Majeed syndrome is one of the rarest diseases in the world, there are no medications specifically FDA-approved to treat it ^[1]. Instead, doctors use off-label treatments—medications approved for other conditions that work on the same biological pathways. Your child’s treatment plan will be highly individualized, focusing on cooling down the inflammation and supporting healthy blood production. Evidence for these therapies relies primarily on a small number of case reports and series rather than large clinical trials.

The Targeted Approach: IL-1 Blockade

A major focus in treating Majeed syndrome is the use of IL-1 inhibitors ^[2]. As discussed in the biology section, the disease causes the body to produce too much of a protein called IL-1 beta, which drives bone pain and fever. These medications block that protein before it can cause damage ^[1][3].

Common IL-1 Inhibitors

Responses vary, but these drugs have been reported to improve symptoms in some patients:

• Anakinra (Kineret): This is a daily injection. It has been reported to improve bone pain, resolve skin rashes, and in some cases, help the bone marrow start producing healthy red blood cells again ^[4]. Because it leaves the body quickly, it is often used first so doctors can see how a child reacts to it.
• Canakinumab (Ilaris): This is an injection given much less frequently. It can provide remission for some children, making it an option for long-term maintenance in those who respond well ^[5][6].

Other Treatment Options

While IL-1 inhibitors are often discussed, other medications may be used depending on the child’s phenotype and the specialist’s guidance:

• NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Medications like naproxen or ibuprofen are often the first line of defense for bone pain (CRMO) ^[7]. However, they require individualized dosing and careful monitoring for kidney and gastrointestinal risks ^[2].
• Bisphosphonates: These are drugs that can help reduce bone pain in children with severe bone lesions ^[8]. However, they require specialist consideration of kidney function and calcium/vitamin D status, and they have limited Majeed-specific evidence ^[9].
• Corticosteroids: These are powerful anti-inflammatories used for short-term control during a severe flare. They are generally not used long-term due to side effects like growth suppression and bone thinning ^[7][10].

Managing the Anemia (CDA)

Treatment for Majeed syndrome involves more than just controlling bone inflammation. The Congenital Dyserythropoietic Anemia (CDA) component requires its own management plan led by a hematologist.

• Some children may require blood transfusions. Repeated transfusions can cause iron overload, which requires separate monitoring and sometimes chelation therapy.
• The hematologist will monitor hemoglobin, reticulocyte counts, and iron studies. Do not start iron supplements without your doctor confirming a true iron deficiency, as iron overload can be dangerous.
• While IL-1 blockade has improved anemia in some reported cases, it does not reliably correct the marrow problem for every child ^[2].

Managing Risks and Side Effects

Because these treatments work by calming the immune system, they also reduce the body’s ability to fight off infections.

Serious Harms and Infection Planning

• Severe Infection: This is the most significant risk. Because biologic drugs can “mask” a fever, a minor infection could become serious before you notice it ^[11][12]. You must have a written flare/infection plan detailing when to call the doctor and when to go to the ER. Do not hold, stop, or restart a biologic unless the prescribing team or an emergency clinician directs you to.
• Vaccines: Review your child’s immunization status before starting biologic therapy. Live vaccines typically must be avoided or timed differently while on immunosuppressants, though some non-live vaccines remain important ^[13].
• Injection-Site Reactions: Most children experience some redness, itching, or pain where the shot is given, especially with anakinra ^[11]. This usually improves over time.
• Liver and Blood Monitoring: In rare cases, anakinra has been linked to liver irritation or a drop in white blood cell counts ^[14][6]. Your doctor will schedule regular blood tests to monitor your child’s liver function and blood counts ^[13][15].
• Allergic Reactions: While rare, some children can have a severe allergic reaction (anaphylaxis) to these medications ^[16]. If your child develops hives, difficulty breathing, or swelling of the face after a dose, seek emergency care immediately ^[17].

Long-Term Monitoring

Treatment is not just about stopping the pain; it is about ensuring your child grows and develops normally. Your medical team will likely use:

1. Repeat MRIs: To ensure bone lesions are healing ^[4][18].
2. Blood Counts (CBC): To check that the anemia is resolving ^[4][13].
3. Growth Charts: To monitor for “catch-up” growth as inflammation is brought under control ^[19].

Success is often measured by improved energy levels, stable growth, and a child who is finally able to play with less pain ^[4][2].